These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9157964)

  • 1. Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells.
    Lesnik P; Dachet C; Petit L; Moreau M; Griglio S; Brudi P; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):979-88. PubMed ID: 9157964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.
    Rojstaczer N; Triggle DJ
    Biochem Pharmacol; 1996 Jan; 51(2):141-50. PubMed ID: 8615882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A; Salvayre R
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cholesteryl ester accumulation in P388D1 macrophage-like cells by increased cellular vitamin E depends on species of extracellular cholesterol. Conventional heterologous non-human cell cultures are poor models of human atherosclerotic foam cell formation.
    Asmis R; Llorente VC; Gey KF
    Eur J Biochem; 1995 Oct; 233(1):171-8. PubMed ID: 7588742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of verapamil and nifedipine on cholesteryl ester metabolism and low-density lipoprotein oxidation in macrophages.
    Dushkin MI; Schwartz YS
    Biochem Pharmacol; 1995 Jan; 49(3):389-97. PubMed ID: 7857326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
    Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
    Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages.
    Roma P; Catapano AL; Bertulli SM; Varesi L; Fumagalli R; Bernini F
    Biochem Biophys Res Commun; 1990 Aug; 171(1):123-31. PubMed ID: 2393386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages.
    Fuhrman B; Volkova N; Aviram M
    J Nutr Biochem; 2005 Sep; 16(9):570-6. PubMed ID: 16115546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists and cholesteryl ester metabolism in macrophages.
    Bernini F; Bellosta S; Didoni G; Fumagalli R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S42-5. PubMed ID: 1725002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidant effect of drugs used in cardiovascular therapy].
    Silva JM; Filipe PM; Fernandes AC; Manso CF
    Rev Port Cardiol; 1998 Jun; 17(6):495-503. PubMed ID: 9677827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
    Maor I; Hayek T; Coleman R; Aviram M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper.
    Yue TL; McKenna PJ; Lysko PG; Ruffolo RR; Feuerstein GZ
    Atherosclerosis; 1992 Dec; 97(2-3):209-16. PubMed ID: 1361324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
    Lupo E; Locher R; Weisser B; Vetter W
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1803-8. PubMed ID: 7945331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally.
    Dhaliwal BS; Steinbrecher UP
    J Lipid Res; 2000 Oct; 41(10):1658-65. PubMed ID: 11013308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
    Maor I; Mandel H; Aviram M
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine.
    Stengel D; Antonucci M; Gaoua W; Dachet C; Lesnik P; Hourton D; Ninio E; Chapman MJ; Griglio S
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1172-80. PubMed ID: 9672079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic importance of the combination atenolol/nifedipine in hypertensive patients].
    Carré A
    Drugs; 1998; 56 Suppl 2():23-30. PubMed ID: 9813739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidative action of the novel calcium channel antagonist mibefradil on low-density lipoproteins.
    Leonhardt W; Lange M
    Eur J Clin Pharmacol; 1998 Oct; 54(8):603-7. PubMed ID: 9860146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E supplementation of human macrophages prevents neither foam cell formation nor increased susceptibility of foam cells to lysis by oxidized LDL.
    Asmis R; Jelk J
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2078-86. PubMed ID: 10978252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.